RVL Pharmaceuticals plc 3 SEC Filings

Filed On	Filing
12 Aug 2022	Form 3: Lask Alisa, Director Holds 9,557 shares of Ordinary Shares
12 Aug 2022	Form 3: Athyrium Opportunities Iv Acquisition 2 Lp, 10% owner and 6 others Holds 8,148,832 shares of Ordinary Shares
22 Apr 2022	Form 3: DePetris Michael, Principal Accounting Officer No securities owned
01 Oct 2019	Form 3: DeBiasi Michael J., Director No securities owned
02 Jan 2019	Form 3: Cowan Gregory L, Director No securities owned
18 Oct 2018	Form 3: Vergez Juan Augusto, Director No securities owned
18 Oct 2018	Form 3: Sielecki Carlos Alberto, Director No securities owned
18 Oct 2018	Form 3: Harsaul Foundation, 10% owner Holds 20,235,297 shares of Ordinary Shares
18 Oct 2018	Form 3: Altchem Ltd, 10% owner and 1 other Holds 20,235,297 shares of Ordinary Shares
18 Oct 2018	Form 3: deVries Tina Marie, EVP, Research & Development
18 Oct 2018	Form 3: Schaub James, EVP and COO Holds 159,503 shares of Ordinary Shares
18 Oct 2018	Form 3: Klein Christopher, General Counsel and Secretary Holds 60,183 shares of Ordinary Shares
18 Oct 2018	Form 3: Einhorn Andrew J., Chief Financial Officer Holds 8,567 shares of Ordinary Shares
18 Oct 2018	Form 3: Markison Brian A, Director Holds 1,488,242 shares of Ordinary Shares
18 Oct 2018	Form 3: Weiss Fred G, Director No securities owned
18 Oct 2018	Form 3: Venkataraman Sriram, Director Holds 8,654,948 shares of Ordinary Shares
18 Oct 2018	Form 3: Burgstahler David F, Director Holds 8,654,948 shares of Ordinary Shares
18 Oct 2018	Form 3: Avista Capital Partners Iii GP, L.p., 10% owner and 4 others Holds 8,654,948 shares of Ordinary Shares

Comments